Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Neurocrine Adds Epilepsy Assets From Xenon
Xenon will have freedom to focus on later-stage pipeline
Dec 02 2019
•
By
Joseph Haas
Neurocrine thinks XEN901 offers potential in multiple epilepsy indications
More from Strategy
More from Business